Edition:
India

People: Amneal Pharmaceuticals Inc (AMRX.N)

AMRX.N on New York Stock Exchange

3.98USD
25 Nov 2020
Change (% chg)

$-0.12 (-2.93%)
Prev Close
$4.10
Open
$4.10
Day's High
$4.11
Day's Low
$3.90
Volume
220,281
Avg. Vol
259,776
52-wk High
$5.78
52-wk Low
$2.40

Jain, Sanjay 

Mr. Sanjay Jain serves as President - India of the Company. Sanjay has oversight for all aspects of Amneal India operations, including managing the overall productivity and quality deliverables. He has extensive experience managing Operations, Validation and Quality, as well as Regulatory audits originating from the USFDA, MHRA, EU, TGA, Anvisa, MCC and Health Canada. Prior to joining Amneal, Sanjay held Quality and Operations positions at Ranbaxy Laboratories, Zydus Cadila, Torrent Pharmaceuticals, Cadila Pharmaceuticals, Intas Pharmaceuticals, Bharat Parenterals and Mesco Pharmaceuticals. He has developed quality systems, implemented various process improvement projects, developed and audited API vendor sites across the globe and successfully faced regulatory audits of various regulatory agencies multiple times. He is a member of the International Society for Pharmaceutical Engineering (ISPE) and Parenteral Drug Association (PDA and an accomplished speaker at various international conferences.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --